Cranberry Pomace Polyphenol Composition for Blood Glucose Control
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for metabolic syndrome focus on individual components rather than the core syndrome, and pharmacological interventions are not effective or well-tolerated by all individuals, highlighting a need for a natural composition that can treat the underlying metabolic syndrome and enhance known pharmacological treatments.
Innovation Solution
A composition comprising an aqueous and ethanol soluble, whole cranberry-derived stress adapted bioactive ingredient profile enriched in polyphenolics, produced by drying the leach juice of cranberry pomace, which is used to reduce blood glucose levels, increase insulin activity, inhibit alpha-glucosidase and alpha-amylase activities, and lower blood pressure, thereby addressing symptoms of metabolic syndrome.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If pharmacological interventions are used to treat metabolic syndrome, then blood glucose and blood pressure can be controlled, but side effects increase and tolerability decreases
Solution Approach 1:
The patent replaces long-term pharmacological treatments with a natural cranberry-based composition that can be consumed regularly without accumulating harmful effects. The composition uses natural polyphenolics and stress-adapted bioactives that provide therapeutic benefits without the severe side effects of conventional drugs, allowing for sustainable long-term use.
Solution Approach 2:
The patent changes the fundamental parameter of treatment from synthetic pharmacological agents to natural plant-derived compounds. By using cranberry pomace extracts enriched with polyphenolics and stress-adapted bioactives, the treatment achieves blood glucose and blood pressure control through natural mechanisms rather than drug-based interventions, thereby reducing side effects.
2Ease of operation
If current treatments focus on individual components of metabolic syndrome, then specific symptoms can be managed, but the core syndrome remains untreated
Solution Approach 1:
The cranberry-based composition is designed to address multiple aspects of metabolic syndrome simultaneously. It contains polyphenolics that improve insulin sensitivity, stress-adapted bioactives that regulate blood pressure, and other compounds that manage lipid profiles and inflammation. This multi-functional approach treats the core syndrome rather than just individual symptoms.
Solution Approach 2:
The patent combines multiple bioactive compounds from cranberry pomace into a single integrated composition. Rather than treating insulin resistance, hypertension, and dyslipidemia as separate conditions requiring separate medications, the composition merges multiple therapeutic agents into one natural product that addresses all components of metabolic syndrome concurrently.
3Reliability
If conventional drugs are used at high dosage and frequency, then therapeutic effect is maximized, but side effects and treatment burden increase
Solution Approach 1:
The natural cranberry composition can be taken at lower doses and less frequently compared to conventional medications. The body metabolizes and eliminates the natural compounds more safely, allowing for reduced dosing frequency while maintaining therapeutic effectiveness. This reduces the treatment burden on patients.
Solution Approach 2:
The composition leverages the body's natural metabolic pathways to process and utilize the cranberry bioactives. The stress-adapted bioactives in the composition work synergistically with the body's own regulatory mechanisms, enhancing insulin sensitivity and blood pressure control through natural physiological processes rather than forcing artificial drug-based corrections.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The cranberry-derived composition effectively lowers blood glucose and glycosylated hemoglobin levels, increases insulin sensitivity, and reduces cardiovascular risk factors by potentiating insulin activity and inhibiting key enzymes, with fewer side effects compared to traditional treatments, and can be used in conjunction with conventional drugs to decrease their dosage and frequency.
Implementation Method 1
inhibit alpha-glucosidase and alpha-amylase activities
Implementation Method 2
increase insulin activity, potentiating insulin activity
Implementation Method 3
enriched in polyphenolics-containing SABs
Data Source
AI summary
Compositions of a whole fruit-derived cranberry ingredient profile, enriched in Stress Adapted Bioactive (SABs) from cranberries are described, for use in reducing the blood glucose level of diabetic, prediabetic, or other hyperglycemic individuals and individuals having one or more metabolic syndrome related factors. The compositions are prepared from whole fruit-derived cranberry pomace, which may be liquid or powdered, and which is enriched in Stress Adapted Bioactives (SABs) and enriched in soluble polyphenolics. Methods for using whole cranberry ingredient profile, enriched in polyphenolic-containing SABs, for the management of individuals having one or more symptoms of metabolic syndrome and for minimizing the effects of the syndrome are disclosed.